Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667095 · ClinicalTrials.gov registry record · Phase 3
Over Active Bladder Instillation Study - Botox
A Phase 3 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 3
- Development phase
- 25
- Enrollment target
NCT00667095: Clinical Trial Phase 3 study, sponsored by Mayo Clinic.
NCT00667095 is a Phase 3 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00667095, a Phase 3 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether women with overactive bladder (OAB) who receive direct instillation via a catheter of a Botulinum-A Toxin (Botox) with Dimethyl Sulfoxide (DMSO) solution experience significantly better improvement of their OAB symptoms when compared to a similar group of women with OAB who receive instillation of DMSO only.
Interventions
- DRUG Botox Instillation
- DRUG DMSO Instillation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00667095
The ClinicalTrials.gov registry entry for NCT00667095 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Botox Instillation is the first listed.
NCT00667095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00667095 about?
NCT00667095 is a clinical study titled "Over Active Bladder Instillation Study - Botox". The purpose of this study is to determine whether women with overactive bladder (OAB) who receive direct instillation via a catheter of a Botulinum-A Toxin (Botox) with Dimethyl Sulfoxide (DMSO) solution experience significantly better improvement of their OAB symptoms when compared to a similar gro...
What is the current status of trial NCT00667095?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 25 participants. The study started on 2008-04. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00667095?
The interventions under investigation include: Botox Instillation (DRUG), DMSO Instillation (DRUG).
Who is sponsoring clinical trial NCT00667095?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.